First quarter 2020 financial report

24. Apr 2020 | 1 min read

Moss, 24 April 2020

Gentian Diagnostics AS announces its results for the first quarter of 2020.

The highlights include:

  • Record sales revenues of MNOK 16.2 in 1Q20, up from MNOK 10.6 in 1Q19
  • Sales growth of 53 % is based on strong performance of all product lines. Sales grew by 42 % YoY on a currency neutral basis
  • New publications of clinical study results confirm GCAL as a promising biomarker for earlier detection and better prediction of severity of an infection

Please find the report and results presentation here:

GDAS 1Q 2020 Interim report

GDAS 1Q Interim Presentation

 

For further information, please contact:

Hilja Ibert CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242

Njaal Kind CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525

MeldingsID: 503693
UtstederID: GENT-ME
Marked: Merkur Market

You may also read


May 14, 2020 - Julie

MINUTES OF ANNUAL GENERAL MEETING

The Annual General Meeting of Gentian Diagnostics AS was held 14 May 2020. All proposed resolutions on the..

Apr 29, 2020 - Julie

Notice of Annual General Meeting

The 2020 Annual General Meeting of Gentian Diagnostics AS will be held on 14 May 2020 at 10:00 (CEST) at..

Apr 24, 2020 - Julie

2019 Annual Report

The Board of Gentian Diagnostics AS has approved the Annual Report for 2019. The Annual Report is without..